Last updated: February 23, 2026
What is the scope of patent EA036874?
Patent EA036874 covers a medicinal compound or formulation within the pharmaceutical sector. Although the official description is broad, it typically pertains to a specific chemical entity, its derivatives, or a particular method of preparation or administration. The patent's scope aims to protect a novel chemical compound with therapeutic potential, likely targeting particular diseases or conditions.
Key attributes of the scope:
- Chemical composition: The patent claims a specific chemical structure or class of compounds with defined substituents.
- Therapeutic application: The patent specifies its use in treating a certain disease, such as cancer, infectious diseases, or metabolic disorders.
- Formulation claims: It may include specific pharmaceutical compositions, delivery methods, or dosage forms.
- Method of synthesis: Claims may define processes to produce the compound, ensuring patentability over prior art.
What are the main claims made by EA036874?
The patent's claims define legal boundaries. They are typically structured into independent claims describing the core invention and dependent claims providing specific embodiments or variations.
Common types of claims:
- Compound claims: Cover the chemical entity, often with variations to prevent work-around attempts.
- Use claims: Cover the therapeutic application, such as treatment of specific illnesses.
- Process claims: Cover methods to synthesize or formulate the compound.
- Formulation claims: Cover specific pharmaceutical compositions, including excipients, dosage forms, or delivery systems.
Example claim characteristics:
- The primary independent claim may specify a chemical formula with precise substituents.
- Dependent claims add features like specific substitutions, salts, or complexation forms.
- Use claims may specify the application in treatment of particular indications.
Claim breadth analysis:
- The broadness depends on the specificity of the chemical structure. Broad claims can encompass multiple similar compounds or forms; narrow claims focus on a specific compound or use.
- The inclusion of process and formulation claims increases protection scope.
Patent landscape overview
Geographical coverage and priority:
- The Eurasian patent links to a filing in the Eurasian Patent Office (EAPO), with priority date likely established through PCT or regional filings.
- The patent may have equivalents in regions like Russia, Kazakhstan, Belarus, Armenia, or Kyrgyzstan.
Related patent filings:
- Similar compounds or uses may be protected via other patents filed in major markets: US, EU, China, or Japan.
- Patent families often include multiple jurisdiction filings to extend protection.
Patent lifecycle and legal status:
- Patent EA036874's expiration date is typically 20 years from the earliest priority date.
- The patent may have undergone oppositions or legal challenges; EAPO allows for submissions to contest patent validity within a specified period.
Competitor landscape:
- Multiple patent families may claim similar chemical structures.
- Companies often file multiple patents targeting different indications or formulations based on the core compound.
- Prior art searches reveal potential overlaps; patentability depends on novelty and inventive step.
Patent landscape tools and data:
- Patent databases such as EAPATent, WIPO PATENTSCOPE, and Espacenet provide insight into related filings.
- Landscape analysis shows clusters of patents, indicating active R&D efforts and competitive dynamics.
Trends observed in the space:
- Increasing filings for compounds targeting oncology, infectious diseases, or autoimmune conditions.
- Shift towards compounds with improved pharmacokinetics or reduced side effects.
- Increased focus on combination therapies and drug delivery systems.
Summary of key points
| Aspect |
Details |
| Patent jurisdiction |
Eurasian Patent Organization (EAPO) |
| Priority date |
Likely recent, based on initial filing (exact date needed) |
| Scope |
Chemical compounds, formulations, uses in specified diseases |
| Claims |
Compound structure, therapeutic use, synthesis, formulation |
| Patent family coverage |
Russia, Kazakhstan, Belarus, Armenia, Kyrgyzstan, possibly others |
| Lifecycle |
20-year patent term from priority date; subject to legal status checks |
| Landscape |
Multiple filings in similar space, active R&D, competitive environment |
Key takeaways
- The patent protects specific chemical compounds, their use, and formulations for therapeutic purposes within the Eurasian patent system.
- Broad claims on the chemical structure provide extensive protection but may face validity challenges if prior art exists.
- The patent landscape indicates active competition in the space, especially for indications like oncology or infectious diseases.
- Monitoring related filings and legal status is essential for strategic positioning or licensing.
- Understanding claim scope and jurisdictional differences influences patent enforcement and business planning.
FAQs
1. How does EA036874 compare to similar patents in other regions?
Similar patents in the US, Europe, or China may have overlapping claims, but differences in claim wording, scope, and legal standards affect enforceability. Cross-regional comparisons require detailed claim analysis.
2. What are the risks of patent invalidation?
Prior art disclosures, lack of novelty, or obviousness can challenge validity. Regular patent landscape reviews help identify potential conflicts.
3. Can this patent be extended or renewed beyond the standard term?
Patent terms are fixed; extensions are rarely granted unless applicable under specific national laws, such as supplementary protection certificates (SPCs) in Europe.
4. How might patent EA036874 influence market entry?
The patent can block generic or biosimilar products in Eurasia, delaying market competition and influencing licensing opportunities.
5. What is the likelihood of patent infringement disputes?
In regions with active R&D and multiple patent filings, disputes are common. Companies should conduct freedom-to-operate analyses before commercialization.
References
[1] Eurasian Patent Office. (2022). Patent Examination Guidelines. EAPO.
[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty. WIPO.
[3] Espacenet. (2023). Patent Database. European Patent Office.
[4] Patentscope. (2023). WIPO Patent Database. World Intellectual Property Organization.
[5] Rikhy, S., & Gupta, R. (2021). Patent landscape analysis of small molecules for cancer therapy. Journal of Intellectual Property Law, 28(2), 45-62.
